These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 17852003)

  • 1. Antiretroviral therapy in the lives of women of colour with HIV.
    Wayson Locher A; Pargament K; Duggan J
    AIDS Care; 2007 Sep; 19(8):1048-51. PubMed ID: 17852003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the cultural context of HIV stigma on antiretroviral therapy adherence among people living with HIV/AIDS in southwest Nigeria.
    Okoror TA; Falade CO; Olorunlana A; Walker EM; Okareh OT
    AIDS Patient Care STDS; 2013 Jan; 27(1):55-64. PubMed ID: 23305262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "I want to stand on my own legs": A qualitative study of antiretroviral therapy adherence among HIV-positive women in Egypt.
    Badahdah AM; Pedersen DE
    AIDS Care; 2011 Jun; 23(6):700-4. PubMed ID: 21476148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to antiretroviral therapy: a survey of factors associated with medication usage.
    Duggan JM; Locher A; Fink B; Okonta C; Chakraborty J
    AIDS Care; 2009 Sep; 21(9):1141-7. PubMed ID: 20024773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "It is not that I forget, it's just that I don't want other people to know": barriers to and strategies for adherence to antiretroviral therapy among HIV patients in Northern Vietnam.
    Van Tam V; Pharris A; Thorson A; Alfven T; Larsson M
    AIDS Care; 2011 Feb; 23(2):139-45. PubMed ID: 21259125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection.
    Williams PL; Storm D; Montepiedra G; Nichols S; Kammerer B; Sirois PA; Farley J; Malee K;
    Pediatrics; 2006 Dec; 118(6):e1745-57. PubMed ID: 17101712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-infected patients' adherence to highly active antiretroviral therapy: a phenomenological study.
    Mohammadpour A; Yekta ZP; Nikbakht Nasrabadi AR
    Nurs Health Sci; 2010 Dec; 12(4):464-9. PubMed ID: 21210925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers to antiretroviral medication adherence in HIV-infected women.
    Roberts KJ; Mann T
    AIDS Care; 2000 Aug; 12(4):377-86. PubMed ID: 11091770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions about the acceptability of assessments of HIV medication adherence in Lilongwe, Malawi and Chennai, India.
    Safren SA; Kumarasamy N; Hosseinipour M; Harwood MM; Hoffman I; McCauley M; Jumbe A; Nyirenda C; Mimiaga MJ; Solomon S; Celentano D; Mayer KH
    AIDS Behav; 2006 Jul; 10(4):443-50. PubMed ID: 16604297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased health care utilization and increased antiretroviral use in HIV-infected individuals with mental health disorders.
    Mijch A; Burgess P; Judd F; Grech P; Komiti A; Hoy J; Lloyd JH; Gibbie T; Street A
    HIV Med; 2006 May; 7(4):205-12. PubMed ID: 16630032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women.
    Mellins CA; Chu C; Malee K; Allison S; Smith R; Harris L; Higgins A; Zorrilla C; Landesman S; Serchuck L; Larussa P
    AIDS Care; 2008 Sep; 20(8):958-68. PubMed ID: 18608073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applying an expanded social determinant approach to the concept of adherence to treatment: the case of Colombian women living with HIV/AIDS.
    Arrivillaga M; Ross M; Useche B; Springer A; Correa D
    Womens Health Issues; 2011; 21(2):177-83. PubMed ID: 21177122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of lipoatrophy on patient-reported outcomes in antiretroviral-experienced patients.
    Doward LC; Dietz B; Wilburn J; McKenna SP; Bhor M; Rajagopalan R
    AIDS Read; 2008 May; 18(5):242-6, 252-6, 262-4. PubMed ID: 18589480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "We are just supposed to be quiet": the production of adherence to antiretroviral treatment in urban Tanzania.
    Mattes D
    Med Anthropol; 2011 Mar; 30(2):158-82. PubMed ID: 21400351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pill taking from the perspective of HIV-Infected women who are vulnerable to antiretroviral treatment failure.
    Stevens PE; Hildebrandt E
    Qual Health Res; 2009 May; 19(5):593-604. PubMed ID: 19258590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral therapy in Zambia: colours, 'spoiling', 'talk' and the meaning of antiretrovirals.
    Schumaker LL; Bond VA
    Soc Sci Med; 2008 Dec; 67(12):2126-34. PubMed ID: 18952338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Supposed to make you better but it doesn't really": HIV-positive youths' perceptions of HIV treatment.
    Veinot TC; Flicker SE; Skinner HA; McClelland A; Saulnier P; Read SE; Goldberg E
    J Adolesc Health; 2006 Mar; 38(3):261-7. PubMed ID: 16488824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An information-motivation-behavioral skills model of adherence to antiretroviral therapy.
    Fisher JD; Fisher WA; Amico KR; Harman JJ
    Health Psychol; 2006 Jul; 25(4):462-73. PubMed ID: 16846321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bridging the gap between antiretroviral access and adherence in Mexico.
    Campero L; Herrera C; Kendall T; Caballero M
    Qual Health Res; 2007 May; 17(5):599-611. PubMed ID: 17478643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.